Specifically in osteosarcoma, inhibition of TIM-3 and increased CD8+ T cell infiltration has been shown to inhibit tumor growth, suggesting the potential for immunotherapy targeting T cell exhaustion (13, 23). The gene discussed is HAVCR2; the disease is neoplasm.